1. Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention
    Yan Yu et al, 2021, World Journal of Clinical Cases CrossRef
  2. “No-Reflow” Phenomenon: A Contemporary Review
    Gianmarco Annibali et al, 2022, Journal of Clinical Medicine CrossRef
  3. Efficacy and Safety of Local Intracoronary Drug Delivery in Treatment of No‐Reflow Phenomenon: A Pilot Study
    Tamer Abu Arab et al, 2016, Journal of Interventional Cardiology CrossRef
  4. Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon
    Joseph Allencherril et al, 2019, Cardiovascular Drugs and Therapy CrossRef
  5. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial
    Sheraz A. Nazir et al, 2016, European Heart Journal CrossRef
  6. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis
    Xiaowei Niu et al, 2018, BMC Cardiovascular Disorders CrossRef
  7. Combined Primary PCI with Multiple Thrombus Burden Reduction Therapy Improved Cardiac Function in Patients with Acute Anterior Myocardial Infarction
    Kun Wang et al, 2019, International Heart Journal CrossRef
  8. Management of No-Reflow Phenomenon in the Catheterization Laboratory
    Shereif H. Rezkalla et al, 2017, JACC: Cardiovascular Interventions CrossRef
  9. A Multi Target and Multi Timing Strategy for the Management of Coronary Microvascular Obstruction
    Francesco Fracassi et al, 2018, Coronary Microvascular Obstruction in Acute Myocardial Infarction CrossRef
  10. Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study
    Eliano P. Navarese et al, 2021, Catheterization and Cardiovascular Interventions CrossRef
  11. Compendium of STEMI Clinical Trials
    Juanita Gonzalez Arango et al, 2017, Manual of STEMI Interventions CrossRef
  12. Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction
    S. V. Dil et al, 2022, Cardiovascular Therapy and Prevention CrossRef
  13. Primary angioplasty after distal intracoronary infusion of nicorandil solution mixed with contrast media
    Udaya Prashant Ponangi, 2020, BMJ Case Reports CrossRef
  14. Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factor-κB, monocyte chemoattractant protein-1, activator protein-1 and restoration of heat shock protein 72
    XUEFENG LIN et al, 2015, Molecular Medicine Reports CrossRef
  15. Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon
    Gagan Kaur et al, 2021, International Journal of Angiology CrossRef
  16. Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry
    Stavroula Papapostolou et al, 2018, EuroIntervention CrossRef
  17. Prevention of Coronary Microvascular Obstruction by Addressing Ischemia Reperfusion Injury—Part A
    Thomas Stiermaier et al, 2018, Coronary Microvascular Obstruction in Acute Myocardial Infarction CrossRef
  18. Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon
    Gagan Kaur et al, 2022, International Journal of Angiology CrossRef
  19. Prophylactic use of intracoronary sodium nitroprusside decreases incidence of no reflow after primary angioplasty in acute myocardial infarction
    Sujith Kumar et al, 2021, Kerala Heart Journal CrossRef
  20. Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial
    CHUNHONG CHEN et al, 2015, Experimental and Therapeutic Medicine CrossRef
  21. Intracoronary Administration of Drugs in Clinical Practice
    Sergii V. Salo et al, 2022, Ukrainian Journal of Cardiovascular Surgery CrossRef
  22. Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management
    Jathinder Kumar et al, 2019, Expert Review of Cardiovascular Therapy CrossRef
  23. Effects of different routes of tirofiban injection on the left ventricular function and prognosis of patients with myocardial infarction treated with percutaneous coronary intervention
    CUIHUA ZHAO et al, 2015, Experimental and Therapeutic Medicine CrossRef
  24. The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of microvascular obstruction during primary percutaneous coronary intervention
    Sheraz A Nazir et al, 2016, Efficacy and Mechanism Evaluation CrossRef
  25. Effect of Intracoronary Nitroprusside in Preventing No Reflow Phenomenon during Primary Percutaneous Coronary Intervention: A Meta‐Analysis
    SHIJIE ZHAO et al, 2014, Journal of Interventional Cardiology CrossRef
  26. The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial
    Sheraz A Nazir et al, 2014, Trials CrossRef